Paralytics


Neuromuscular-blocking agents also known as paralytics block neuromuscular transmission at neuromuscular junction, causing loss of motion of skeletal muscles. This is accomplished similarly by acting presynaptically through the inhibition of acetylcholine (ACh) synthesis and by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. While a few medications act presynaptically, (for example, botulinum toxin and tetanus poison), those of current clinical significance work postsynaptically. Because the appropriate dose of neuromuscular-blocking medication may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should to be provided to maintain adequate respiration.


    Related Conference of Paralytics

    December 07-08, 2020

    4th Annual Summit on Surgery and Transplantation

    Vienna, Austria
    February 22-23, 2021

    8th International Conference on Rhinology & Otology

    Tokyo, Japan
    March 24-25, 2021

    6th European Otolaryngology Ent Surgery Conference

    Paris, France
    May 10-11, 2021

    12th European Conference on Surgery & Cosmetology

    Barcelona, Spain
    May 13-14, 2021

    4th World Congress on Surgeons

    Bali, Indonesia
    May 17-18, 2021

    14th World Congress on Anesthesiology and Critical Care

    Prague, Czech Republic
    September 20-21, 2021

    6th International Conference on Anesthesia

    Rome, Italy
    October 26-27, 2021

    4th International Conference on Craniofacial Surgery

    Madrid, Spain
    December 01-02, 2021

    7th European Otolaryngology-ENT Surgery Conference

    Barcelona, Spain

    Paralytics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in